{
    "info": {
        "nct_id": "NCT05025423",
        "official_title": "Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma",
        "inclusion_criteria": "* Subjects must have a histologically confirmed diagnosis of mantle cell lymphoma as defined by the World Health Organization (WHO) classification scheme.\n* Age ≥ 60\n* Subjects must be previously untreated for mantle cell lymphoma and deemed to require treatment by the treating physician\n* ECOG performance status of 0-3\n* Subject must have adequate bone marrow* without growth factor support as follows:\n\n  * Absolute Neutrophil Count (ANC) ≥ 1000/μL\n  * Platelets ≥ 75,000/mm3 (entry platelet count must be independent of transfusion within 14 days of Screening)\n  * Hemoglobin ≥ 9.0 g/dL * These criteria may be waived by study investigators if there is evidence of bone marrow involvement by MCL that is believed to be the cause of the cytopenias.\n* Subject must have adequate renal, and hepatic function, per laboratory reference range at screening as follows:\n\n  * Subject must have adequate renal, and hepatic function, per laboratory reference range at screening as follows:\n  * Calculated creatinine clearance ≥ 40 mL/min; determined via the Cockcroft-Gault formula.\n  * AST and ALT ≤ 3.0 × ULN; Bilirubin ≤ 1.5 × ULN*. Subjects with Gilbert's Syndrome may have a bilirubin > 1.5 × ULN\n\n    * These criteria may be waived by study investigators if abnormal values believed to be due to lymphoma.\n* Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or have negative results for a pregnancy test performed as follows:\n\n  * At Screening on a serum sample obtained within 14 days prior to the first study drug administration, and\n  * Prior to dosing on a urine sample obtained on Cycle 1 Day 1 if it has been > 7 days since obtaining the serum pregnancy test results.\n  * All female subjects not surgically sterile or postmenopausal (for at least 1 year) and non-vasectomized male subjects must practice at least 1 of the following methods of birth control:\n\n    1. Total abstinence from sexual intercourse (minimum 1 complete menstrual cycle);\n    2. A vasectomized partner(s);\n    3. Hormonal contraceptives (oral, parenteral, vaginal ring or transdermal) for at least 3 months prior to study drug administration;\n    4. Double-barrier method (condoms and diaphragm with spermicidal [sponge, jellies or creams]).\n* Ability to understand and willingness to sign IRB-approved informed consent\nHealthy volunteers allowed\nMust have minimum age of 60 Years",
        "exclusion_criteria": "* Subject has blastoid-variant mantle cell lymphoma\n* Subject requires immediate cytoreduction as determined by study investigators\n* Subject has documented CNS involvement of mantle cell lymphoma\n* Subject has Ann Arbor stage I or contiguous stage II mantle cell lymphoma\n* Subject has an uncontrolled infection\n* Subject has HIV infection\n* All subjects will be screened for Hepatitis B (HBsAg, anti-HBs, anti-HBc IgM and total) and Hepatitis C (antibody or RNA). Subjects who are positive for Hepatitis B by HBsAg or DNA as well as subjects positive for Hepatitis C will be excluded. Subjects with anti-HBc positivity and DNA negative may be included but will be required to undergo monthly HBV DNA testing and liver function liver function testing (AST, ALT, alkaline phosphatase, total bilirubin). Patients with HCV antibody positivity and HCV pcr negativity are eligible to be included.\n* Subject requires the use of warfarin\n* Subject has received immunization with live virus vaccine within 28 days prior to the first dose of study drug\n* A female subject is pregnant or breast-feeding",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Subject must have adequate renal, and hepatic function, per laboratory reference range at screening as follows:",
            "criterions": [
                {
                    "exact_snippets": "adequate renal ... per laboratory reference range at screening",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "reference_range",
                            "expected_value": "per laboratory reference range at screening"
                        }
                    ]
                },
                {
                    "exact_snippets": "adequate ... hepatic function, per laboratory reference range at screening",
                    "criterion": "hepatic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "reference_range",
                            "expected_value": "per laboratory reference range at screening"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Calculated creatinine clearance ≥ 40 mL/min; determined via the Cockcroft-Gault formula.",
            "criterions": [
                {
                    "exact_snippets": "Calculated creatinine clearance ≥ 40 mL/min; determined via the Cockcroft-Gault formula.",
                    "criterion": "creatinine clearance",
                    "requirements": [
                        {
                            "requirement_type": "calculated value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 40,
                                "unit": "mL/min"
                            }
                        },
                        {
                            "requirement_type": "calculation method",
                            "expected_value": "Cockcroft-Gault formula"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* AST and ALT ≤ 3.0 × ULN; Bilirubin ≤ 1.5 × ULN*. Subjects with Gilbert's Syndrome may have a bilirubin > 1.5 × ULN",
            "criterions": [
                {
                    "exact_snippets": "AST ... ≤ 3.0 × ULN",
                    "criterion": "AST (aspartate aminotransferase) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3.0,
                                "unit": "ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "ALT ≤ 3.0 × ULN",
                    "criterion": "ALT (alanine aminotransferase) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3.0,
                                "unit": "ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Bilirubin ≤ 1.5 × ULN ... Subjects with Gilbert's Syndrome may have a bilirubin > 1.5 × ULN",
                    "criterion": "bilirubin level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "ULN"
                            }
                        },
                        {
                            "requirement_type": "exception",
                            "expected_value": "Subjects with Gilbert's Syndrome may have a bilirubin > 1.5 × ULN"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Platelets ≥ 75,000/mm3 (entry platelet count must be independent of transfusion within 14 days of Screening)",
            "criterions": [
                {
                    "exact_snippets": "Platelets ≥ 75,000/mm3",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 75000,
                                "unit": "mm3"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "entry platelet count must be independent of transfusion within 14 days of Screening",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "independence from transfusion",
                            "expected_value": {
                                "operator": ">",
                                "value": 14,
                                "unit": "days before Screening"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject must have adequate renal, and hepatic function, per laboratory reference range at screening as follows:",
            "criterions": [
                {
                    "exact_snippets": "adequate renal ... per laboratory reference range at screening",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": "per laboratory reference range at screening"
                        }
                    ]
                },
                {
                    "exact_snippets": "adequate ... hepatic function, per laboratory reference range at screening",
                    "criterion": "hepatic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": "per laboratory reference range at screening"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Total abstinence from sexual intercourse (minimum 1 complete menstrual cycle);",
            "criterions": [
                {
                    "exact_snippets": "Total abstinence from sexual intercourse (minimum 1 complete menstrual cycle)",
                    "criterion": "sexual intercourse",
                    "requirements": [
                        {
                            "requirement_type": "abstinence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "menstrual cycle"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. A vasectomized partner(s);",
            "criterions": [
                {
                    "exact_snippets": "A vasectomized partner(s)",
                    "criterion": "partner vasectomy status",
                    "requirements": [
                        {
                            "requirement_type": "vasectomized",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Absolute Neutrophil Count (ANC) ≥ 1000/μL",
            "criterions": [
                {
                    "exact_snippets": "Absolute Neutrophil Count (ANC) ≥ 1000/μL",
                    "criterion": "absolute neutrophil count (ANC)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1000,
                                "unit": "/μL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects must have a histologically confirmed diagnosis of mantle cell lymphoma as defined by the World Health Organization (WHO) classification scheme.",
            "criterions": [
                {
                    "exact_snippets": "histologically confirmed diagnosis of mantle cell lymphoma",
                    "criterion": "mantle cell lymphoma diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": "histological"
                        }
                    ]
                },
                {
                    "exact_snippets": "as defined by the World Health Organization (WHO) classification scheme",
                    "criterion": "mantle cell lymphoma diagnosis definition",
                    "requirements": [
                        {
                            "requirement_type": "classification scheme",
                            "expected_value": "World Health Organization (WHO)"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 60 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 60 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* These criteria may be waived by study investigators if abnormal values believed to be due to lymphoma.",
            "criterions": [
                {
                    "exact_snippets": "criteria may be waived by study investigators if abnormal values believed to be due to lymphoma",
                    "criterion": "abnormal laboratory values",
                    "requirements": [
                        {
                            "requirement_type": "waiver_possible",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "cause_of_abnormality",
                            "expected_value": "lymphoma"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or have negative results for a pregnancy test performed as follows:",
            "criterions": [
                {
                    "exact_snippets": "Female subjects must be surgically sterile",
                    "criterion": "surgical sterility",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "postmenopausal (for at least 1 year)",
                    "criterion": "postmenopausal status",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "negative results for a pregnancy test",
                    "criterion": "pregnancy test result",
                    "requirements": [
                        {
                            "requirement_type": "test result",
                            "expected_value": "negative"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects must be previously untreated for mantle cell lymphoma and deemed to require treatment by the treating physician",
            "criterions": [
                {
                    "exact_snippets": "previously untreated for mantle cell lymphoma",
                    "criterion": "mantle cell lymphoma treatment history",
                    "requirements": [
                        {
                            "requirement_type": "treatment history",
                            "expected_value": "no prior treatment"
                        }
                    ]
                },
                {
                    "exact_snippets": "deemed to require treatment by the treating physician",
                    "criterion": "requirement for treatment as determined by physician",
                    "requirements": [
                        {
                            "requirement_type": "physician assessment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Double-barrier method (condoms and diaphragm with spermicidal [sponge, jellies or creams]).",
            "criterions": [
                {
                    "exact_snippets": "Double-barrier method (condoms and diaphragm with spermicidal [sponge, jellies or creams])",
                    "criterion": "contraception method",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "condoms",
                                "diaphragm"
                            ]
                        },
                        {
                            "requirement_type": "use_with",
                            "expected_value": "spermicidal (sponge, jellies or creams)"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hemoglobin ≥ 9.0 g/dL * These criteria may be waived by study investigators if there is evidence of bone marrow involvement by MCL that is believed to be the cause of the cytopenias.",
            "criterions": [
                {
                    "exact_snippets": "Hemoglobin ≥ 9.0 g/dL",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 9.0,
                                "unit": "g/dL"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "criteria may be waived ... if there is evidence of bone marrow involvement by MCL that is believed to be the cause of the cytopenias",
                    "criterion": "bone marrow involvement by MCL causing cytopenias",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Hormonal contraceptives (oral, parenteral, vaginal ring or transdermal) for at least 3 months prior to study drug administration;",
            "criterions": [
                {
                    "exact_snippets": "Hormonal contraceptives (oral, parenteral, vaginal ring or transdermal) for at least 3 months prior to study drug administration",
                    "criterion": "hormonal contraceptive use",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "oral",
                                "parenteral",
                                "vaginal ring",
                                "transdermal"
                            ]
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to study drug administration"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior to dosing on a urine sample obtained on Cycle 1 Day 1 if it has been > 7 days since obtaining the serum pregnancy test results.",
            "criterions": [
                {
                    "exact_snippets": "urine sample obtained on Cycle 1 Day 1 if it has been > 7 days since obtaining the serum pregnancy test results",
                    "criterion": "urine sample",
                    "requirements": [
                        {
                            "requirement_type": "collection_time",
                            "expected_value": "Cycle 1 Day 1"
                        }
                    ]
                },
                {
                    "exact_snippets": "> 7 days since obtaining the serum pregnancy test results",
                    "criterion": "serum pregnancy test results",
                    "requirements": [
                        {
                            "requirement_type": "time_since_collection",
                            "expected_value": {
                                "operator": ">",
                                "value": 7,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject must have adequate bone marrow* without growth factor support as follows:",
            "criterions": [
                {
                    "exact_snippets": "adequate bone marrow* without growth factor support",
                    "criterion": "bone marrow function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "growth factor support",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age ≥ 60",
            "criterions": [
                {
                    "exact_snippets": "Age ≥ 60",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* All female subjects not surgically sterile or postmenopausal (for at least 1 year) and non-vasectomized male subjects must practice at least 1 of the following methods of birth control:",
            "criterions": [
                {
                    "exact_snippets": "All female subjects not surgically sterile or postmenopausal (for at least 1 year)",
                    "criterion": "female reproductive status",
                    "requirements": [
                        {
                            "requirement_type": "surgical sterility",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "postmenopausal status",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "non-vasectomized male subjects",
                    "criterion": "male vasectomy status",
                    "requirements": [
                        {
                            "requirement_type": "vasectomized",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "must practice at least 1 of the following methods of birth control",
                    "criterion": "birth control method usage",
                    "requirements": [
                        {
                            "requirement_type": "usage",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability to understand and willingness to sign IRB-approved informed consent",
            "criterions": [
                {
                    "exact_snippets": "Ability to understand",
                    "criterion": "ability to understand informed consent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willingness to sign IRB-approved informed consent",
                    "criterion": "willingness to sign informed consent",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "type of consent",
                            "expected_value": "IRB-approved informed consent"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status of 0-3",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status of 0-3",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* At Screening on a serum sample obtained within 14 days prior to the first study drug administration, and",
            "criterions": [
                {
                    "exact_snippets": "At Screening on a serum sample obtained within 14 days prior to the first study drug administration",
                    "criterion": "serum sample",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days prior to first study drug administration"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Subject requires the use of warfarin",
            "criterions": [
                {
                    "exact_snippets": "Subject requires the use of warfarin",
                    "criterion": "warfarin use",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has received immunization with live virus vaccine within 28 days prior to the first dose of study drug",
            "criterions": [
                {
                    "exact_snippets": "received immunization with live virus vaccine within 28 days prior to the first dose of study drug",
                    "criterion": "immunization with live virus vaccine",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days prior to the first dose of study drug"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has an uncontrolled infection",
            "criterions": [
                {
                    "exact_snippets": "uncontrolled infection",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject requires immediate cytoreduction as determined by study investigators",
            "criterions": [
                {
                    "exact_snippets": "Subject requires immediate cytoreduction",
                    "criterion": "immediate cytoreduction requirement",
                    "requirements": [
                        {
                            "requirement_type": "necessity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "as determined by study investigators",
                    "criterion": "study investigator determination of cytoreduction requirement",
                    "requirements": [
                        {
                            "requirement_type": "determination",
                            "expected_value": "study investigators"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has documented CNS involvement of mantle cell lymphoma",
            "criterions": [
                {
                    "exact_snippets": "documented CNS involvement of mantle cell lymphoma",
                    "criterion": "CNS involvement of mantle cell lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has Ann Arbor stage I or contiguous stage II mantle cell lymphoma",
            "criterions": [
                {
                    "exact_snippets": "Ann Arbor stage I or contiguous stage II mantle cell lymphoma",
                    "criterion": "mantle cell lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "Ann Arbor stage",
                            "expected_value": [
                                "I",
                                "contiguous II"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has blastoid-variant mantle cell lymphoma",
            "criterions": [
                {
                    "exact_snippets": "blastoid-variant mantle cell lymphoma",
                    "criterion": "blastoid-variant mantle cell lymphoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject has HIV infection",
            "criterions": [
                {
                    "exact_snippets": "Subject has HIV infection",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* All subjects will be screened for Hepatitis B (HBsAg, anti-HBs, anti-HBc IgM and total) and Hepatitis C (antibody or RNA). Subjects who are positive for Hepatitis B by HBsAg or DNA as well as subjects positive for Hepatitis C will be excluded. Subjects with anti-HBc positivity and DNA negative may be included but will be required to undergo monthly HBV DNA testing and liver function liver function testing (AST, ALT, alkaline phosphatase, total bilirubin). Patients with HCV antibody positivity and HCV pcr negativity are eligible to be included.",
            "criterions": [
                {
                    "exact_snippets": "screened for Hepatitis B (HBsAg, anti-HBs, anti-HBc IgM and total)",
                    "criterion": "Hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "screening",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "screened for ... Hepatitis C (antibody or RNA)",
                    "criterion": "Hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "screening",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Subjects who are positive for Hepatitis B by HBsAg or DNA ... will be excluded",
                    "criterion": "Hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "positivity (HBsAg or DNA)",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "subjects positive for Hepatitis C will be excluded",
                    "criterion": "Hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "positivity",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Subjects with anti-HBc positivity and DNA negative may be included but will be required to undergo monthly HBV DNA testing and liver function ... testing (AST, ALT, alkaline phosphatase, total bilirubin)",
                    "criterion": "Hepatitis B core antibody positivity with negative HBV DNA",
                    "requirements": [
                        {
                            "requirement_type": "anti-HBc positivity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "HBV DNA negativity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "monthly HBV DNA testing",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "monthly liver function testing (AST, ALT, alkaline phosphatase, total bilirubin)",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Patients with HCV antibody positivity and HCV pcr negativity are eligible to be included",
                    "criterion": "Hepatitis C antibody positivity with negative HCV PCR",
                    "requirements": [
                        {
                            "requirement_type": "HCV antibody positivity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "HCV PCR negativity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* A female subject is pregnant or breast-feeding",
            "criterions": [
                {
                    "exact_snippets": "A female subject is pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "breast-feeding",
                    "criterion": "breast-feeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}